Lion's Mane Mushroom (Hericium erinaceus)

Lion's mane marketing leans on fear of dementia: «protects the brain from Alzheimer's», «restores neurons», «natural memantine». The Mori 2009 RCT is the only available double-blind trial, and it enrolled 30 Japanese adults with MCI, not Alzheimer's disease. The 1.3-point HDS-R effect after 16 weeks with return to baseline after stopping is a weak symptomatic signal, not disease modification. RCTs in patients with established Alzheimer's, vascular, or frontotemporal dementia are absent. NICE NG97 recommends cholinesterase inhibitors (donepezil, rivastigmine, galantamine) in mild-moderate Alzheimer's and memantine in moderate-severe disease; primary prevention runs through blood-pressure, diabetes, and lipid control, smoking cessation, exercise, a Mediterranean diet, hearing-loss management, and social engagement. The WHO Dementia Fact Sheet 2023 and the Alzheimer's Association point out: no «brain health» supplement modifies the course of dementia, and «natural memantine» marketing is unsupported by clinical data. A real risk of lion's mane in suspected dementia is delaying neurologic or geriatric assessment and losing the window when approved drugs still work. If lion's mane was bought for a relative with Alzheimer's, consider seeking a second opinion – NICE NG97 dementia management does not include mushroom supplements.

ICD-10: F03 · ICD-11: 6D8Z

Lion's mane is an edible mushroom marketed as a «natural nootropic» and «nerve growth factor stimulant» for memory, concentration, and productivity. The evidence base is weak. The double-blind RCT by Mori (Phytother Res 2009) in 30 Japanese patients aged 50–80 with mild cognitive impairment showed a 1.3-point improvement on the HDS-R scale after 16 weeks of 3 g/day of dried lion's mane powder and a return to baseline 4 weeks after discontinuation – the clinical significance of this difference is debatable. The open-label Saitsu trial (Biomed Res 2019) in 31 adults aged 50–80 reported cognitive improvement after 12 weeks – without placebo control or blinding. In healthy adults without cognitive decline, in young users for «productivity», or in students before exams, lion's mane has not been studied for memory or concentration – no RCTs. NCCIH lists lion's mane among supplements without proven cognitive benefit. Real evidence-based interventions for memory and concentration are aerobic activity 150 minutes per week, a Mediterranean or MIND diet, 7–9 hours of sleep, treatment of sleep apnoea, correction of B12 and iron deficiency, and alcohol moderation. If lion's mane was bought «for the brain», consider seeking a second opinion – memory complaints warrant ruling out depression, hypothyroidism, B12 deficiency, and sleep disorders rather than taking mushroom powder.

Lion's mane is marketed as a «natural anxiolytic» and «adaptogen» for stress and anxiety. The double-blind RCT by Nagano (Biomed Res 2010) in 30 menopausal Japanese women with anxiety and poor sleep reported lower ICED and DBSO scores after 4 weeks of cookies containing 2 g/day of lion's mane powder. The sample is tiny, the population specific, no confirmatory RCTs exist, and major anxiety guidelines do not list lion's mane. NICE recommends cognitive behavioural therapy for generalised anxiety and panic disorder as first-line, and SSRIs (sertraline, escitalopram, paroxetine) or SNRIs (venlafaxine, duloxetine) in moderate-severe disease; Spanish SEPyN holds a comparable algorithm. None of these guidelines refer to «adaptogens», a marketing term coined in 1940s Soviet science without an accepted definition. If «stress» reflects burnout, the answer is rest and workload review, not a supplement; if anxiety interferes with work and sleep, consider seeking a second opinion with a primary-care physician or psychiatrist – guidelines do not propose lion's mane.

ICD-10: F41.9 · ICD-11: 6B0Z

Lion mane (Hericium erinaceus) is an edible mushroom sold as a supplement for memory, focus, and mood under the superfood and adaptogen label. There is no convincing evidence that it improves cognition or eases anxiety in people; the available studies are small and low quality. Memory and attention actually benefit from sleep, physical activity, treating the underlying condition, and keeping blood pressure and glucose in range when they are off. Do not take this mushroom in place of a therapy with proven benefit, since that can mean missing the treatment you need.